SOLO LAB / DOCUMENTATION GUIDE

How to read a peptide Certificate of Analysis

A Certificate of Analysis (COA) reports tests on an identified sample. Read it as a record of specific measurements, with a defined scope, rather than a general promise about a product.

1. Match the material and batch before the percentage

Compare the compound name, material description, and batch or lot identifier with the product record and label. A certificate for the same compound but another lot is a different record. If the batch is absent or does not match, ask which document applies instead of transferring the result by assumption.

The WHO model COA connects the tested sample, batch, methods, and results. Its pharmaceutical context provides a useful documentation reference; it does not certify Solo Lab or its products.

2. Check who issued it and whether the report is complete

Look for the issuing laboratory, report identifier, sample identifier, relevant dates, page count, and approval information. Distinguish sample receipt, testing, report issue, and any stated retest or expiry date. They answer different questions. Read all pages and notes, including amendments. The report version control guide covers how to retain the original and document a correction.

When verification is available, use the laboratory’s independently located contact details or verification service. A logo, screenshot, or QR code alone does not establish that a report is authentic or applies to the material. The WHO model describes report identification and approval fields.

3. Read the result, unit, and acceptance criterion together

For each line, identify what was measured, the reported result, its unit or reporting basis, and any stated specification. A measured result and an acceptance limit are different entries. “Pass” without the underlying test and criterion leaves an important question unanswered.

Do not treat “not detected” as proof that absolutely none is present. Interpretation depends on the method and its detection capability. ICH Q2(R2), published by FDA in 2024, distinguishes identity, impurity, and quantitative tests and their performance characteristics.

4. Separate identity, chromatographic purity, and content

Report entryQuestion it addressesDo not infer
Identity evidenceDoes the measured evidence support the stated compound under the reported method?Amount, purity, or suitability from identity alone.
HPLC area purityWhat share of the integrated detector response is attributed to the main component under those conditions?The same percentage of the entire vial’s mass.
Content or quantitative assayHow much analyte was measured, using the stated method and reporting basis?That it was measured if the report only lists area purity.
ConcentrationHow much analyte is present per stated volume or mass?A concentration from a milligram label without the necessary quantity and volume information.

NIST’s archived peptide reference-material report explicitly treats UV area purity, peptide mass purity, and molecular mass as separate measurements. It is cited for that distinction, not as a current certificate or evidence about Solo Lab batches.

For a closer look at reporting bases and independently measured quantities, read Peptide purity vs. content: what a COA percentage means.

5. Check the actual method, not just its acronym

HPLC separates components under specified chromatographic conditions. Mass spectrometry measures ions and can supply molecular-mass evidence. They can complement each other; they do not answer every question interchangeably. A matching mass alone should not be expanded into a claim that every structural feature or possible impurity was established.

Look for a method reference, the reporting basis, and supporting chromatograms or spectra when supplied. Ask the laboratory about unclear peak assignments, integration, co-eluting substances, or identification limits rather than interpreting a small screenshot as a complete method review.

WHO good chromatography practices addresses chromatographic procedures and records. ICH Q2(R2) emphasizes demonstrating that a procedure is fit for its intended analytical purpose. Neither source means a named test automatically validates a seller’s product.

For a closer look at the plots, read HPLC vs. mass spectrometry: separation, mass evidence, and their limits.

6. Identify the questions the report does not answer

A purity or identity result is not a sterility result. It also does not establish endotoxin status, all possible contaminants, stability over time, or a particular unit’s fill quantity. Look for each relevant test explicitly; do not add absent results to the report.

FDA’s March 2026 endotoxin guidance discusses dedicated testing and interpretation in its regulated-product context. It is not a reason to infer that a research material was tested, is sterile, or is appropriate for administration.

7. Keep the document connected to the material

Keep the original report alongside the product name, lot, source, and relevant laboratory record. If material is relabeled or repackaged, ask how its identifier connects to the tested sample. A report is not an inspection of every individual unit.

Product traceability and measurement traceability are also different. NIST explains metrological traceability as a documented connection between a measurement result and reference standards, including uncertainty. A batch number provides a product-record link; by itself it does not establish that calibration chain.

8. Turn gaps into specific questions

Use a short review note instead of a general “looks good” conclusion:

  • Which product, material form, and lot does this report cover?
  • What is the laboratory’s report or sample identifier?
  • Which tests were performed, and what were their results and reporting units?
  • Is a reported percentage area purity, mass fraction, or another assay?
  • Which requested attributes remain untested or unexplained?
  • What connects this tested sample to the material being supplied?

A missing field is a reason to request clarification. It is not a result you can fill in from another seller, an older lot, or a paper about the molecule.

Read the applicable original record

Browse published Lab Results, then compare the original document with the applicable product record. For questions about a specific record, contact Solo Lab with the product and lot. Use the Peptide Guide for compound research context; published studies do not establish a seller’s batch identity, purity, or safety.

Sources and scope

Sources checked October 16, 2026. These analytical and documentation references do not imply regulatory approval, laboratory accreditation, or testing claims for Solo Lab.

  1. WHO model certificate of analysis, TRS 1010, Annex 4 (2018): documentation fields and the scope of a sample-specific report.
  2. NIST RM 8327 archived report (2007): area purity, mass purity, and molecular-mass measurements; the archived reference values are not current product specifications.
  3. FDA / ICH Q2(R2), Validation of Analytical Procedures (March 2024): analytical purpose, selectivity, and method performance.
  4. WHO good chromatography practices, TRS 1025, Annex 4 (2020): chromatographic procedures and records.
  5. FDA, Pyrogen and Endotoxins Testing: Questions and Answers (March 2026): dedicated endotoxin testing and its scope.
  6. NIST, Metrological Traceability: Frequently Asked Questions and Policy: measurement traceability and uncertainty.

QUICK ADD

Choose your options

Choose a product option and quantity. Checkout opens order review; it does not place an order or submit payment.

21+ · Research only. Not for human or animal consumption.

SOLO LAB PEPTIDES

BEFORE YOU ENTER

21+ RESEARCH ACCESS

You must be at least 21 years old. Products are exclusively for laboratory research and must not be consumed by or administered to humans or animals. Personal use, self-experimentation, medical and veterinary use are prohibited.

EXIT SITE

Research Use PolicyEligibility / 21+Privacy

This is age self-attestation, not identity verification. Acceptance is remembered for 30 days, or until the disclosures change. No date of birth is collected.